Argent Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Argent Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-188,140	Closed	-$3.97M	–	194
2019 Q2	$3.97M	Sell	188,140 -21,410	-10%	-$448K	0.15%	71
2019 Q1	$4.28M	Sell	209,550 -25,800	-11%	-$578K	0.16%	66
2018 Q4	$4.68M	Sell	235,350 -425	-0.2%	-$8.38K	0.24%	58
2018 Q3	$4.54M	Hold	235,775	–	–	0.16%	69
2018 Q2	$3.6M	Buy	235,775 +5,000	+2%	+$87.4K	0.13%	84
2018 Q1	$4.33M	Buy	230,775 +1,035	+0.5%	+$19.5K	0.16%	67
2017 Q4	$4.28M	Buy	229,740 +108,465	+89%	+$2.03M	0.15%	72
2017 Q3	$2.17M	Buy	121,275 +61,425	+103%	+$1.01M	0.08%	111
2017 Q2	$1.07M	Buy	+59,850	New	+$949K	0.04%	134

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Argent Capital Management's AMPH Position: Q3 2019 in Review

Argent Capital Management sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2019, closing a stake of 188,140 shares — an estimated $3.97M sold.

Argent Capital Management first reported a position in AMPH in Q2 2017 and held it in 9 quarters. The position peaked at $4.68M in Q4 2018. 134 funds tracked by Wall St. Rank hold AMPH as of Q3 2019.

Argent Capital Management reported no remaining Amphastar Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Argent Capital Management sold 188,140 Amphastar Pharmaceuticals shares in Q3 2019, an estimated $3.97M.
Argent Capital Management first reported a position in Amphastar Pharmaceuticals in Q2 2017 and held it in 9 quarters.
Argent Capital Management's Amphastar Pharmaceuticals position peaked at $4.68M in Q4 2018.
134 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2019.

Based on Argent Capital Management's 13F filing for Q3 2019, filed 7 Nov 2019.